Guggenheim raises target for Danaher stock from USD 200.00 to USD 250.00
Published on 10/02/2026 at 13:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Guggenheim raised its Danaher price target from USD 200.00 to USD 250.00 on October 1, 2026, while keeping a Buy rating, according to Markets Insider. Danaher stock was trading at EUR 190.00 at Lang & Schwarz on October 2, 2026 at 1:08 p.m. CEST, up 0.73 percent from the prior close of EUR 188.63.
Leadership changes on October 1
Danaher said Julie Sawyer Montgomery assumed the roles of president and chief executive officer on October 1, 2026. Rainer Blair stepped away from the executive positions and is staying as a senior advisor through March 31, 2027, according to the company release.
The timing puts the new CEO in place before Danaher's next operating update. The company has scheduled its third-quarter 2026 earnings conference call for October 21, 2026, at 8:00 a.m. ET, according to the investor-relations calendar.
Targets rise as growth stays measured
Guggenheim's USD 250.00 target is 18.07 percent above the USD 211.74 Danaher quote on the NYSE at the latest finance snapshot dated October 1, 2026. The target revision therefore gives the market a sharply higher valuation reference even as the euro quote remains below its U.S. dollar equivalent.
Danaher reported USD 6.3 billion of revenue for the second quarter of 2026, USD 870.0 million of consolidated net income and USD 1.23 of GAAP diluted earnings per share, according to Financial Report Insights. Revenue rose 5.5 percent from the year-earlier quarter, while core sales growth was 3.0 percent and reached 4.5 percent excluding respiratory testing, according to the second-quarter earnings discussion published by Yahoo Finance.
Danaher stock holds a measured position
The primary-exchange quote was USD 211.74 on October 1, 2026, against a 52-week range of USD 160.93 to USD 242.80. Danaher's market capitalization stood at USD 148.9 billion on that date, leaving the stock 12.79 percent below its 52-week high.
The combination of a new CEO, a scheduled October earnings update and a higher Guggenheim target gives investors three concrete reference points. The operating figures show improving underlying growth, but the 3.0 percent core-sales increase also keeps execution central to the next report. The further course of trading is shown by the continuously updated real-time quote of Danaher stock.
Danaher stock facts
- Company: Danaher Corporation
- ISIN: US2358511028
- WKN: 866197
- Ticker: DHR
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 2, 2026, 1:08 p.m. CEST): EUR 190.00
- Change versus prior close: plus 0.73 percent
- Prior close Lang & Schwarz (October 1, 2026): EUR 188.63
- Market capitalization: USD 148.9 billion (as of October 1, 2026)
- 52-week range: USD 160.93-242.80 (as of October 1, 2026)
- Sector / Industry: Healthcare / Medical - Diagnostics and Research
- Next earnings date: October 21, 2026
